home
about us
member log-in
contact us

PRODUCTS
MUNICIPAL BONDS
INDEX FUNDS
- Total Asset Fund (TAF)
EVENTS
MARKET RESEARCH

Recent Quotes

View Full List

My Watchlist

Indicators

Markets:

Overview

News

Currencies

International

Treasuries

Quanterix Corporation - Common Stock (NQ:QTRX)

2.790 +0.150 (+5.68%)

Streaming Delayed Price Updated: 9:46 AM EDT, May 22, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about Quanterix Corporation - Common Stock

< Previous 1 2 3 4 5 6 7 8 9 10 Next >

Stocks That Hit 52-Week Lows On Tuesday ↗

March 15, 2022

During Tuesday's session, 454 stocks hit new 52-week lows. Intriguing Points From Today's 52-Week Lows: Taiwan Semiconductor (NYSE:TSM) was the largest company by...

Via Benzinga

Quanterix's Return On Capital Employed Insights ↗

March 08, 2022

Quanterix (NASDAQ:QTRX) brought in sales totaling $30.29 million during Q4 according to data provided by Benzinga Pro. However, earnings decreased 27.87%, resulting in a loss of $...

Via Benzinga

Benzinga's Top Ratings Upgrades, Downgrades For March 2, 2022 ↗

March 02, 2022

Upgrades Barclays upgraded the previous rating for Equitrans Midstream Corp (NYSE:ETRN) from Underweight to Equal-Weight. Equitrans Midstream earned $0.07 in the fourth...

Via Benzinga

Recap: Quanterix Q4 Earnings ↗

March 01, 2022

Quanterix (NASDAQ:QTRX) reported its Q4 earnings results on Tuesday, March 1, 2022 at 08:00 AM. Here's what investors need to know about the announcement. Earnings...

Via Benzinga

Earnings Scheduled For March 1, 2022 ↗

March 01, 2022

Companies Reporting Before The Bell • Precigen (NASDAQ:PGEN) is expected to report earnings for its fourth quarter. • TG Therapeutics (NASDAQ:TGTX) is estimated...

Via Benzinga

Quanterix Corporation to Release Fourth Quarter and Full Year 2021 Financial Results on March 1, 2022

February 23, 2022

From Quanterix Corporation

Via Business Wire

Quanterix to Participate in the SVB Leerink Global Healthcare Conference

February 09, 2022

From Quanterix Corporation

Via Business Wire

UK Dementia Research Institute Biomarker Factory Powers Alzheimer’s Disease Breakthroughs with Quanterix Simoa® Technology

February 07, 2022

From Quanterix Corporation

Via Business Wire

Quanterix’ Simoa® Technology Powers Latest Breakthrough in Epstein-Barr Virus and Multiple Sclerosis

January 26, 2022

From Quanterix

Via Business Wire

Quanterix Provides Operational and Preliminary Financial Highlights

January 13, 2022

From Quanterix Corporation

Via Business Wire

Quanterix to Present at 40th Annual J.P. Morgan Healthcare Conference

January 06, 2022

From Quanterix Corporation

Via Business Wire

Quanterix Recognized as a Fastest-Growing Company in North America on the 2021 Deloitte Technology Fast 500™

November 17, 2021

From Quanterix Corporation

Via Business Wire

Quanterix’ Simoa® Technology Powers Advances in Alzheimer’s Disease Research Presented at 2021 Clinical Trials on Alzheimer’s Disease (CTAD) Conference

November 16, 2021

From Quanterix Corporation

Via Business Wire

Quanterix to Participate in the Canaccord Genuity Virtual MedTech, Diagnostics and Digital Health & Services Forum

November 11, 2021

From Quanterix Corporation

Via Business Wire

Quanterix Co-Inventor of Simoa® David Walt Receives Kabiller Prize in Nanoscience and Nanomedicine

November 08, 2021

From Quanterix Corporation

Via Business Wire

Quanterix Corporation (QTRX) Q3 2021 Earnings Call Transcript ↗

November 05, 2021

QTRX earnings call for the period ending September 30, 2021.

Via The Motley Fool

Topics Earnings

Quanterix Corporation Releases Operating Results for Third Quarter of 2021

November 04, 2021

From Quanterix

Via Business Wire

Quanterix Corporation to Release Third Quarter 2021 Financial Results on Nov. 4, 2021

October 28, 2021

From Quanterix

Via Business Wire

45 Biggest Movers From Yesterday ↗

October 13, 2021

Gainers ESSTech Inc (NYSE: GWH) shares surged 128.4% to close at $23.80 onTuesday. ESS Inc, the Bill Gates-backed battery maker went public on the NewYork Stock Exchange on...

Via Benzinga

12 Health Care Stocks Moving In Tuesday's Intraday Session ↗

October 12, 2021

Gainers NRX Pharmaceuticals (NASDAQ:NRXP...

Via Benzinga

30 Stocks Moving In Tuesday's Mid-Day Session ↗

October 12, 2021

Gainers ESS Tech Inc (NYSE: GWH) shares jumped 96.4% to $20.46. ESS Inc, the Bill Gates-backed battery maker went public on the New York Stock Exchange on Monday after...

Via Benzinga

Why Shares of Quanterix Are Climbing This Morning ↗

October 12, 2021

Regulators are helping accelerate an early test for Alzheimer's disease.

Via The Motley Fool

12 Health Care Stocks Moving In Tuesday's Pre-Market Session ↗

October 12, 2021

Gainers Viridian Therapeutics (NASDAQ:VRDN) stock rose 22.49% to $19.17 during Tuesday's pre-market session. The company's market cap stands at $331.8 million. Inhibrx (...

Via Benzinga

15 Stocks Moving in Tuesday's Pre-Market Session ↗

October 12, 2021

Gainers Quanterix Corporation (NASDAQ: QTRX) shares rose 17.6% to $48.55 in pre-market trading after the company announced its Simoa phospho-Tau 181 blood test has been granted...

Via Benzinga

Quanterix Granted Breakthrough Device Designation from U.S. FDA for Blood-Based pTau-181 Assay for Alzheimer’s Disease

October 11, 2021

From Quanterix Corporation

Via Business Wire

Quanterix Hosts Webinar with Leading Pathologist from Emory Medical Laboratories

September 20, 2021

From Quanterix Corporation

Via Business Wire

FDA Expands Quanterix's COVID-19 Antigen Test Emergency Use Label ↗

September 14, 2021

The FDA has expanded the Emergency Use Authorization (EUA) label for Quanterix Corporation's (NASDAQ: QTRX) Simoa SARS-CoV-2 N Protein Antigen Test. The...

Via Benzinga

Quanterix Receives Label Expansion on Emergency Use Authorization for COVID Antigen Test

September 13, 2021

From Quanterix Corporation

Via Business Wire

Quanterix to Host Webinar with Leading Pathologist from Emory Medical Laboratories: “COVID-19 Testing in a Residential University Setting: Implementation, Insights, and Learnings”

September 10, 2021

From Quanterix Corporation

Via Business Wire

Return On Capital Employed Insights For Quanterix ↗

September 03, 2021

Benzinga Pro data, Quanterix (NASDAQ:QTRX) reported Q2 sales of $25.37 million. Earnings fell to a loss of $13.67 million, resulting in a 39.63% decrease from last quarter. In Q1...

Via Benzinga

< Previous 1 2 3 4 5 6 7 8 9 10 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.

Home
About Us
Products
Municipal Bonds
Index Funds
Seminars & Events
Market Research
Contact Us
Member Section
Privacy Policy
Terms & Conditions
Security Notice
Customer Service

Securities offered through Purshe Kaplan Sterling Investments, member FINRA / SIPC, Headquartered at 80 State Street,
Albany, NY 12207
Purshe Kaplan Sterling Investments and Tamar Securities, LLC are not affiliated companies.
Tamar Securities, LLC is a Registered Investment Adviser. Advisory services are only offered to clients or prospective clients where Tamar Securities, LLC
and its representatives are properly licensed or exempt from licensure. Past performance is no guarantee of future returns. Investing involves risk and possible loss of principal capital.
No advice may be rendered by Tamar Securities, LLC unless a client service agreement is in place.

NOT FDIC INSURED. NOT BANK GUARANTEED. MAY LOSE VALUE, INCLUDING LOSS OF PRINCIPAL. NOT INSURED BY ANY STATE OR FEDERAL AGENCY.
Web development by IBCnet.com